MedPath

Modulating Brain Activity to Improve Goal-directed Physical Activity in Older Adults

Not Applicable
Completed
Conditions
Aging
Interventions
Device: Sham stimulation
Device: Transcranial direct current stimulation (tDCS)
Behavioral: Behavioral intervention to increase physical activity
Registration Number
NCT04278560
Lead Sponsor
Hebrew SeniorLife
Brief Summary

Although the majority of older adults are aware of the compelling evidence that regular exercise is critical to the maintenance of health into old age, most do not meet recommendations for daily exercise. This lack of engagement in 'goal-directed' physical activity stems from numerous interrelated factors including lack of motivation, depressed mood, and cognitive "executive" impairments that diminish one's ability to regulate behavior over time. Intriguingly, each of these factors has been linked to the function of brain networks that include the left dorsolateral prefrontal cortex (dlPFC). Transcranial direct current stimulation (tDCS) is a noninvasive and safe means of modulating the excitability of specific brain regions and their connected neural networks. tDCS designed to facilitate the excitability of the left dlPFC has been shown to improve motivation, mood, and multiple aspects of executive function in healthy adults. The investigators thus hypothesize that tDCS holds promise to increase goal-directed physical activity in older adults. This project aims to conduct a pilot randomized controlled trial on the feasibility and effects of a 2-week, 10-session tDCS intervention targeting the left dlPFC, combined with behavioral intervention aimed at increases daily physical activity, on physical activity over a two-month follow-up period, in relatively sedentary older adults without overt illness or disease.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
34
Inclusion Criteria
  • Must live within subsidized housing in the Boston area
  • Self-report of exercising, on average, less than 150 minutes of at least moderate-intensity exercise per week, as determined by phone-screen completion of the International Physical Activity Questionnaire-Short Form (IPAQ short)
Exclusion Criteria
  • An inability to ambulate without the assistance of another person (canes or walkers allowed)
  • Self-report of physician-diagnosed dementia, more than moderate cognitive impairment defined as a Montreal Cognitive Assessment (MoCA) score <21, or an inability to understand the study protocol as determined by study staff
  • A clinical history of stroke, Parkinson's disease or parkinsonian syndromes, multiple sclerosis, normal pressure hydrocephalus or other movement disorder affecting gait
  • Any report of severe lower-extremity arthritis or physician-diagnosis of peripheral neuropathy
  • Use of antipsychotics, anti-seizure, benzodiazepines, or other neuroactive medications
  • Severe depression defined by a Geriatric Depression Scale score greater than 11
  • Any report or physician-diagnosis of schizophrenia, bipolar disorder or other psychiatric illness
  • Any unstable medical condition
  • Resting systolic blood pressure is higher than 180 mmHg
  • Contraindications tor tDCS, including reported seizure within the past two years, use of neuro-active drugs, self-reported presence of specific implanted medical devices (e.g., deep brain stimulator, medication infusion pump, cochlear implant, pacemaker, etc.), or the presence of any active dermatological condition, such as eczema, on the scalp

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Behavioral intervention plus sham stimulationBehavioral intervention to increase physical activityThis intervention will consist of a two-month, personalized, goal-based counseling approach to promote physical activity. Over the first two weeks of the behavioral intervention, participants will also received 10, once-daily, 20-minute sessions of sham stimulation.
Behavioral intervention plus sham stimulationSham stimulationThis intervention will consist of a two-month, personalized, goal-based counseling approach to promote physical activity. Over the first two weeks of the behavioral intervention, participants will also received 10, once-daily, 20-minute sessions of sham stimulation.
Behavioral intervention plus tDCSBehavioral intervention to increase physical activityThis intervention will consist of a two-month, personalized, goal-based counseling approach to promote physical activity. Over the first two weeks of the behavioral intervention, participants will also received 10, once-daily, 20-minute sessions of transcranial direct current stimulation (tDCS) designed to increase the excitability of the left dorsolateral prefrontal cortex.
Behavioral intervention plus tDCSTranscranial direct current stimulation (tDCS)This intervention will consist of a two-month, personalized, goal-based counseling approach to promote physical activity. Over the first two weeks of the behavioral intervention, participants will also received 10, once-daily, 20-minute sessions of transcranial direct current stimulation (tDCS) designed to increase the excitability of the left dorsolateral prefrontal cortex.
Primary Outcome Measures
NameTimeMethod
Change of Daily Step Counts From BaselineWeek 3-4, Week 5-6, Week 7-8, and Week 9-10.

Absolute change in averaged daily step counts from two-week baseline (first two weeks, week 1-2). The specific periods are 1) absolute change in averaged daily step counts in week 3 and 4 from baseline, 2) absolute change in averaged daily step counts at week 5 and 6, from baseline, 3) absolute change in averaged daily step counts in week 7 and 8 from baseline, and 4) absolute change in averaged daily step counts in week 9 and 10 from baseline.

Secondary Outcome Measures
NameTimeMethod
Completion Rate for Brain Stimulation SessionsWeek 4

Ten stimulation sessions were planned for each participant over two weeks. This outcome presents the percentage of the completed brain stimulation sessions.

Montreal Cognitive Assessment (MoCA) Total ScoreBaseline; Week 4; Week 10

Global cognitive function. The range for this test is 0-30, with higher score representing better outcome.

Geriatric Depression Scale (15-item)Baseline; Week 4; Week 10

Number of depressive symptoms. The range for this test is 0-15, with lower score representing better outcome.

Completion Rate for Behavior SessionsWeek 10

Four bi-weekly behaviors sessions were planned for each participant over two months. This outcome presents the percentage of the completed behavior sessions.

Motivation - External Regulation ScoreBaseline; Week 4; Week 10

External Regulation Score was calculated from the Exercise Self-Regulation Questionnaire (SQR-E). External regulation refers to motivation based on external sources such as incentives or coercion. Introjected regulation refers to motivation from an internalized, pressuring voice that was not accepting it as one's own. The External Regulation Score ranges from 4 to 28. The higher scores mean a better outcome.

Timed Up-and-Go (TUG)Baseline; Week 4; Week 10

A common field test of mobility

Trail Making Test (TMT) - ABaseline; Week 4; Week 10

Trail making test (TMT) A is a neuropsychological test of visual attention. The test requires the patient to connect randomly positioned numbered circles in numeric order as quickly as possible. It provides information about visual search speed and speed of processing. The test reliability for TMT A is 0.82. Time is measured in seconds.

Trail Making Test (TMT) - BBaseline; Week 4; Week 10

Trail Making Test (TMT) - B is a neuropsychological test of task switching. The test requires the participants to connect the circles in numeric and alphabetic order as quickly as possible, alternating between numbers and letters. It provides information about executive function. The test reliability for TMT-B is 0.93. Time is measured in seconds.

Trial Locations

Locations (1)

Hebrew Rehabilitation Center

🇺🇸

Roslindale, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath